OPPENHEIMER HOLDINGS INC REACHES $70 MILLION SETTLEMENT FOR LITIGATION CLAIMS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy OPY?
Source: moomoo
Settlement Agreement: Openheimer Holdings has agreed to pay $70 million to settle litigation claims.
Litigation Context: The settlement resolves ongoing legal disputes involving the company.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OPY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OPY
About OPY
Oppenheimer Holdings Inc., through its subsidiaries, is a middle market investment bank and full-service broker-dealer. The Company is engaged in a broad range of activities in the financial services industry, including retail securities brokerage, institutional sales and trading, investment banking (corporate and public finance), equity and fixed income research, market-making, trust services, and investment advisory and asset management services. The Company’s Wealth Management segment provides a comprehensive array of financial services through a network of financial advisors. Its wealth management services include full-service brokerage, wealth planning, and margin lending. Its Capital Markets segment includes investment banking, institutional equities sales, trading, and research, taxable fixed income sales, trading, and research, public finance and municipal trading, as well as the Company's operations in the United Kingdom, Hong Kong and Israel.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
OPPENHEIMER HOLDINGS INC REACHES $70 MILLION SETTLEMENT FOR LITIGATION CLAIMS
- Settlement Agreement: Openheimer Holdings has agreed to pay $70 million to settle litigation claims.
- Litigation Context: The settlement addresses various claims that were brought against the company.
See More
Trump's Executive Order Boosts Psychedelic Stocks Rally
- Policy Catalyst: President Trump's executive order mandates the FDA to prioritize breakthrough therapy drugs, which is expected to accelerate the regulatory approval process for psychedelics, thereby enhancing commercialization pathways and boosting investor confidence in the sector.
- Clinical Trial Support: The order specifically addresses the mental health crisis among veterans, directing the Department of Veterans Affairs to promote participation in clinical trials, which is anticipated to expand the scale of psychedelic drug trials and increase market demand.
- Market Reaction: Compass Pathways saw its stock surge over 35% on Monday, marking its best single-day performance on record, while AtaiBeckley shares climbed more than 25%, reflecting heightened market sentiment and investor confidence in psychedelics.
- Analyst Expectations: Analysts project average price targets implying upside of approximately 169% for AtaiBeckley and 134% for Compass, while Definium's target suggests a potential rise of over 59% in the next year, indicating strong bullish sentiment towards these companies.
See More
Oppenheimer Lowers ServiceNow Price Target to $130
- Price Target Adjustment: Oppenheimer has reduced its price target for ServiceNow from $175 to $130 while maintaining an Outperform rating, reflecting a decrease in valuation multiples across the software sector that could negatively impact the stock price.
- Earnings Expectations: Although Oppenheimer anticipates strong AI metrics and higher margins in the upcoming Q1 earnings report, concerns regarding AI-related disruptions persist, which may undermine investor confidence.
- Market Environment Impact: The firm noted that soft Federal Government activity could adversely affect ServiceNow's organic growth, particularly in critical areas such as current remaining performance obligations and subscription revenue.
- Investment Outlook: While ServiceNow is considered one of the top stocks for the next five years, Oppenheimer believes that other AI stocks may offer greater upside potential and carry less downside risk, prompting investors to evaluate their options carefully.
See More
David Fleming Promoted to Leadership Role at Oppenheimer & Co.
- Leadership Promotion: David Fleming has been promoted to a leadership role within Oppenheimer & Co.'s Private Client Division, overseeing the New York market, and is expected to drive business development and team performance through close collaboration with regional and branch managers.
- San Francisco Branch Management Change: Ron Guidi will take over as Branch Manager in San Francisco, focusing on day-to-day operations and expanding Oppenheimer's presence in the Bay Area, which is anticipated to continue the growth momentum established by Fleming in that office.
- Wealth Management Business Growth: In 2025, Oppenheimer's Wealth Management segment generated over $1 billion in revenue, with Assets Under Management (AUM) reaching $55.2 billion, marking an all-time high and demonstrating the company's strong performance in the high-net-worth client market.
- Team Expansion and Experience: Under Fleming's leadership, the San Francisco branch saw a 36% revenue increase and a 34% asset growth while adding seven advisors, showcasing his capability in building high-performing teams, and Guidi's addition is expected to further solidify these achievements.
See More
Oppenheimer Wealth Management Leadership Changes Announced
- Leadership Promotion: David Fleming has been promoted to a leadership role in the Private Client Division, overseeing the New York market, and is expected to enhance business development and team performance through close collaboration with regional and branch managers, thereby strengthening the company's competitive edge in wealth management.
- New Role for Former Manager: Ron Guidi takes over as Branch Manager in San Francisco, focusing on daily operations and expanding Oppenheimer's market presence in the Bay Area, which is anticipated to continue the growth momentum established by Fleming in that region.
- Significant Performance Growth: In 2025, Oppenheimer's Wealth Management segment generated over $1 billion in revenue, with Assets Under Management (AUM) reaching $55.2 billion, marking an all-time high and demonstrating the company's robust growth potential in the wealth management sector.
- Team Expansion and Expertise: During Fleming's tenure in San Francisco, revenue grew by 36% and assets by 34%, while adding seven advisors, showcasing his exceptional capabilities in servicing high-net-worth clients and building effective teams.
See More
Veteran Dealmaker Joins Technology Group to Expand Coverage
- Executive Appointment: Bill Farmer joins Oppenheimer & Co. Inc. as Managing Director and Head of Aerospace & Defense Technology Investment Banking, focusing on M&A activities that are expected to enhance the firm's market competitiveness.
- Industry Experience: With over 25 years in the industry and more than 100 transactions executed, Farmer strengthens Oppenheimer's expertise in aerospace and defense, covering M&A, capital raises, and valuations.
- Market Dynamics: Farmer's arrival coincides with increased activity in aerospace, defense, and government services as companies adapt to shifting geopolitical dynamics and rising demand for advanced technologies, positioning Oppenheimer to provide more strategic advice to clients.
- Strategic Synergy: He will closely collaborate with equity and debt capital markets teams to drive integrated advice and execution, further enhancing the synergy of Oppenheimer's investment banking platform.
See More
OPPENHEIMER HOLDINGS INC REACHES $70 MILLION SETTLEMENT FOR LITIGATION CLAIMS
- Settlement Agreement: Openheimer Holdings has agreed to pay $70 million to settle litigation claims.
- Litigation Context: The settlement addresses various claims that were brought against the company.
See More
Trump's Executive Order Boosts Psychedelic Stocks Rally
- Policy Catalyst: President Trump's executive order mandates the FDA to prioritize breakthrough therapy drugs, which is expected to accelerate the regulatory approval process for psychedelics, thereby enhancing commercialization pathways and boosting investor confidence in the sector.
- Clinical Trial Support: The order specifically addresses the mental health crisis among veterans, directing the Department of Veterans Affairs to promote participation in clinical trials, which is anticipated to expand the scale of psychedelic drug trials and increase market demand.
- Market Reaction: Compass Pathways saw its stock surge over 35% on Monday, marking its best single-day performance on record, while AtaiBeckley shares climbed more than 25%, reflecting heightened market sentiment and investor confidence in psychedelics.
- Analyst Expectations: Analysts project average price targets implying upside of approximately 169% for AtaiBeckley and 134% for Compass, while Definium's target suggests a potential rise of over 59% in the next year, indicating strong bullish sentiment towards these companies.
See More
Oppenheimer Lowers ServiceNow Price Target to $130
- Price Target Adjustment: Oppenheimer has reduced its price target for ServiceNow from $175 to $130 while maintaining an Outperform rating, reflecting a decrease in valuation multiples across the software sector that could negatively impact the stock price.
- Earnings Expectations: Although Oppenheimer anticipates strong AI metrics and higher margins in the upcoming Q1 earnings report, concerns regarding AI-related disruptions persist, which may undermine investor confidence.
- Market Environment Impact: The firm noted that soft Federal Government activity could adversely affect ServiceNow's organic growth, particularly in critical areas such as current remaining performance obligations and subscription revenue.
- Investment Outlook: While ServiceNow is considered one of the top stocks for the next five years, Oppenheimer believes that other AI stocks may offer greater upside potential and carry less downside risk, prompting investors to evaluate their options carefully.
See More
David Fleming Promoted to Leadership Role at Oppenheimer & Co.
- Leadership Promotion: David Fleming has been promoted to a leadership role within Oppenheimer & Co.'s Private Client Division, overseeing the New York market, and is expected to drive business development and team performance through close collaboration with regional and branch managers.
- San Francisco Branch Management Change: Ron Guidi will take over as Branch Manager in San Francisco, focusing on day-to-day operations and expanding Oppenheimer's presence in the Bay Area, which is anticipated to continue the growth momentum established by Fleming in that office.
- Wealth Management Business Growth: In 2025, Oppenheimer's Wealth Management segment generated over $1 billion in revenue, with Assets Under Management (AUM) reaching $55.2 billion, marking an all-time high and demonstrating the company's strong performance in the high-net-worth client market.
- Team Expansion and Experience: Under Fleming's leadership, the San Francisco branch saw a 36% revenue increase and a 34% asset growth while adding seven advisors, showcasing his capability in building high-performing teams, and Guidi's addition is expected to further solidify these achievements.
See More
Oppenheimer Wealth Management Leadership Changes Announced
- Leadership Promotion: David Fleming has been promoted to a leadership role in the Private Client Division, overseeing the New York market, and is expected to enhance business development and team performance through close collaboration with regional and branch managers, thereby strengthening the company's competitive edge in wealth management.
- New Role for Former Manager: Ron Guidi takes over as Branch Manager in San Francisco, focusing on daily operations and expanding Oppenheimer's market presence in the Bay Area, which is anticipated to continue the growth momentum established by Fleming in that region.
- Significant Performance Growth: In 2025, Oppenheimer's Wealth Management segment generated over $1 billion in revenue, with Assets Under Management (AUM) reaching $55.2 billion, marking an all-time high and demonstrating the company's robust growth potential in the wealth management sector.
- Team Expansion and Expertise: During Fleming's tenure in San Francisco, revenue grew by 36% and assets by 34%, while adding seven advisors, showcasing his exceptional capabilities in servicing high-net-worth clients and building effective teams.
See More
Veteran Dealmaker Joins Technology Group to Expand Coverage
- Executive Appointment: Bill Farmer joins Oppenheimer & Co. Inc. as Managing Director and Head of Aerospace & Defense Technology Investment Banking, focusing on M&A activities that are expected to enhance the firm's market competitiveness.
- Industry Experience: With over 25 years in the industry and more than 100 transactions executed, Farmer strengthens Oppenheimer's expertise in aerospace and defense, covering M&A, capital raises, and valuations.
- Market Dynamics: Farmer's arrival coincides with increased activity in aerospace, defense, and government services as companies adapt to shifting geopolitical dynamics and rising demand for advanced technologies, positioning Oppenheimer to provide more strategic advice to clients.
- Strategic Synergy: He will closely collaborate with equity and debt capital markets teams to drive integrated advice and execution, further enhancing the synergy of Oppenheimer's investment banking platform.
See More
